Local cutaneous allergy to monocomponent insulin.
A case is described of a patient who developed local cutaneous hypersensitivity soon after commencing treatment with monocomponent insulins (MCI). This appears to be the first record of such a case.
D000328:Adult; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D012882:Skin Tests
D007328:Insulin